title: A new cohort of MECP2 mutation screening in unexplained mental retardation: careful re-evaluation is the best indicator for molecular diagnosis.
authors.forename: Anne
authors.initials: A
authors.lastname: Donzel-Javouhey
authors.forename: Christel
authors.initials: C
authors.lastname: Thauvin-Robinet
authors.forename: Veronica
authors.initials: V
authors.lastname: Cusin
authors.forename: Nathalie
authors.initials: N
authors.lastname: Madinier
authors.forename: Eric
authors.initials: E
authors.lastname: Manceau
authors.forename: Dominique
authors.initials: D
authors.lastname: Dipanda
authors.forename: Véronique
authors.initials: V
authors.lastname: Dulieu
authors.forename: Francine
authors.initials: F
authors.lastname: Mugneret
authors.forename: Frédéric
authors.initials: F
authors.lastname: Huet
authors.forename: Jean-Raymond
authors.initials: JR
authors.lastname: Teyssier
authors.forename: Laurence
authors.initials: L
authors.lastname: Faivre
mesh_terms: D001483:Base Sequence; D015331:Cohort Studies; D004247:DNA / Q000235:genetics; D005260:Female; D005820:Genetic Testing; D006801:Humans; D008607:Intellectual Disability / Q000235:genetics*; D008297:Male; D051783:Methyl-CpG-Binding Protein 2 / Q000235:genetics*; D009154:Mutation; D010641:Phenotype; D015518:Rett Syndrome / Q000235:genetics
chemical_list: C497392:MECP2 protein, human; D051783:Methyl-CpG-Binding Protein 2; D004247:DNA